Wendy Stock to Pyridazines
This is a "connection" page, showing publications Wendy Stock has written about Pyridazines.
Connection Strength
0.221
-
Preclinical pharmacokinetic and pharmacodynamic evaluation of dasatinib and ponatinib for the treatment of T-cell acute lymphoblastic leukemia. Leukemia. 2023 06; 37(6):1194-1203.
Score: 0.221